The new University of Illinois Cancer Center Director of Strategic Federally Qualified Health Center (FQHC) Partnership is Ian Jasenof, MD, FACOG, MHA, CPE, the Chief Medical Officer (CMO) of the Mile Square Health Center, the FQHC division of UI Health.
This newly created role is critical in advancing the mission and vision of the Cancer Center by assisting with developing, nurturing and managing strategic partnerships with Mile Square. In this role, Jasenof will report directly to Cancer Center Director, Jan Kitajewski, PhD, while remaining as the CMO of Mile Square.
A senior medical executive with more than two decades of experience, Jasenof is tasked with creating and executing a comprehensive partnership strategy to enhance health care and cancer care access, quality and community engagement.
Strategic FQHC Partnership
Recently, the Cancer Center and Mile Square began enrolling patients, 50 and older of average health, in the PATHFINDER 2 trial led by the biotechnology company GRAIL. The University of Illinois Chicago is the first site in the state to participate in this national study of a clinical test that screens for a shared cancer signal in a sample of patient blood.
The Cancer Center brings to the study a uniquely diverse patient population where nearly 4 out of 5 participants in clinical trials come from underrepresented groups. The trial also offers patients at Mile Square the opportunity for screening with this new multi-cancer detection technology.